Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

05. März 2026 05:55 ET | Quelle: AnalystView Market Insights

From Lab Innovation to Life-Saving Therapies: Gene Editing Therapeutics Market Poised to Hit US$ 6.26 Billion by 2032, Expanding at a 147.20% CAGR Driven by Rapid CRISPR Breakthrough: AnalystView Market Insights

Gene Editing Therapeutics Market size was valued at US$ 11.13 Million in 2024, expanding at a CAGR of 147.20% from 2025 to 2032.
05. März 2026 05:15 ET | Quelle: Research and Markets

Biological Sterilization Monitoring Equipment Market Global Forecast Report 2026-2032: $1.24 Bn Opportunities in Rapid Detection and Automation, Ensuring Compliance, and Supply Chain Resilience

Dublin, March 05, 2026 (GLOBE NEWSWIRE) -- The "Biological Sterilization Monitoring Equipment Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The...
05. März 2026 04:36 ET | Quelle: SNS Insider pvt ltd

Genomics Services Market Projected to Surpass USD 25.18 Billion by 2035; Increasing Genetic Disorders’ Prevalence is Driving Market Growth Globally – SNS Insider

Austin, United States, March 05, 2026 (GLOBE NEWSWIRE) -- Genomics Services Market Size & Growth Analysis: As per SNS Insider Research, The Genomics Services Market size was valued at USD 7.94...
05. März 2026 02:00 ET | Quelle: Admiral Group PLC

Admiral Group Plc Full Year 2025 Results

5 March 2026 2025 Results Highlights Admiral Group reports record profits for 2025 with strong contributions from across the Group 31 December 202531 December 2024% change vs. 2024Group profit...
04. März 2026 17:00 ET | Quelle: Actuate Therapeutics

Actuate Therapeutics to Present at The Citizens Life Sciences Conference

CHICAGO and FORT WORTH, Texas, March 04, 2026 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on...
04. März 2026 16:05 ET | Quelle: BillionToOne, Inc.

BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance

MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that...
04. März 2026 11:00 ET | Quelle: Vishay Intertechnology, Inc.

Vishay Intertechnology RGB LED in 0404 Package Provides Independent Control of Red, True Green, and Blue Chips for Wide Color Range

MALVERN, Pa., March 04, 2026 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE: VSH) today introduced a new tricolor LED that provides luminous intensity to 252 mcd at 5 mA for RGB displays and...
04. März 2026 11:00 ET | Quelle: Geotab Inc.

Geotab Launches ‘Geotab Build’ to Unify Mixed-Fleet Management for the Construction Industry

LAS VEGAS, NV, March 04, 2026 (GLOBE NEWSWIRE) -- Geotab Inc. (“Geotab”), a global leader in connected transportation, video telematics and asset tracking solutions, today announced its commitment...
04. März 2026 08:00 ET | Quelle: NeOnc Technologies Holdings, Inc.

NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET

CALABASAS, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company developing...
04. März 2026 07:30 ET | Quelle: Nexxen International Ltd.

Nexxen Reports Fourth Quarter and Full Year 2025 Financial Results

Expanded into AI-resilient growth channels through enhanced mobile in-app capabilities and the release of Nexxen’s industry-first programmatic Smart TV home screen ad activation solution, which is now...

Vorherige Seite

Nächste Seite